Amount Raised
$175 Million
Round Type
series b
Description
Metagenomi, a genetic medicines company, has raised $175 million in Series B financing.
Funding Insights
Based on industry dataTech investment trends
83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech